We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-0.01%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$170M
AUM Growth
-$3.54M
Cap. Flow
-$1.18M
Cap. Flow %
-0.69%
Top 10 Hldgs %
23.13%
Holding
180
New
28
Increased
33
Reduced
64
Closed
37

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$2.22M
2
LYB icon
LyondellBasell Industries
LYB
+$1.49M
3
CB icon
Chubb
CB
+$1.46M
4
DLTR icon
Dollar Tree
DLTR
+$1.45M
5
AMGN icon
Amgen
AMGN
+$1.17M

Top Sells

Rank Stock Value
1
PB icon
Prosperity Bancshares
PB
+$2.95M
2
ON icon
ON Semiconductor
ON
+$1.24M
3
MRK icon
Merck
MRK
+$1.23M
4
FISV
Fiserv Inc
FISV
+$1.22M
5
AXP icon
American Express
AXP
+$1.09M

Sector Composition

Rank Sector Weight
1 Industrials 22.11%
2 Healthcare 19.78%
3 Consumer Staples 14.05%
4 Financials 9.51%
5 Technology 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TD icon
101
Toronto Dominion Bank
TD
$199B
$533K 0.31%
8,900
-450
-5% -$29.1K
AWK icon
102
American Water Works
AWK
$27.4B
$527K 0.31%
3,600
-350
-9% -$51.8K
TDG icon
103
TransDigm Group
TDG
$60B
$523K 0.31%
710
-335
-32% -$239K
OGN icon
104
Organon & Co
OGN
$3.59B
$519K 0.3%
22,051
-12,478
-36% -$335K
CNC icon
105
Centene
CNC
$33.4B
$476K 0.28%
+7,525
New +$534K
TXT icon
106
Textron
TXT
$13.9B
$473K 0.28%
6,700
-12,300
-65% -$877K
AZN icon
107
AstraZeneca
AZN
$251B
$462K 0.27%
3,325
-100
-3% -$13.5K
CCI icon
108
Crown Castle
CCI
$31.2B
$458K 0.27%
3,420
WCN
109
Waste Connections
WCN
$40.1B
$455K 0.27%
3,274
WMT icon
110
Walmart Inc
WMT
$858B
$448K 0.26%
9,114
+66
+0.7% +$3.13K
PPG icon
111
PPG Industries
PPG
$23.3B
$434K 0.25%
+3,250
New +$419K
WPC icon
112
W.P. Carey
WPC
$15.6B
$429K 0.25%
5,653
-409
-7% -$32.6K
EMR icon
113
Emerson Electric
EMR
$82B
$403K 0.24%
4,623
DAL icon
114
Delta Air Lines
DAL
$51.9B
$400K 0.23%
+11,450
New +$425K
GLW icon
115
Corning
GLW
$124B
$371K 0.22%
+10,525
New +$366K
LRCX icon
116
Lam Research
LRCX
$339B
$358K 0.21%
+6,750
New +$331K
LDOS icon
117
Leidos
LDOS
$16.2B
$328K 0.19%
3,563
-200
-5% -$19.3K
DAR icon
118
Darling Ingredients
DAR
$10.5B
$323K 0.19%
5,525
-250
-4% -$15.7K
DCI icon
119
Donaldson
DCI
$10.1B
$309K 0.18%
4,725
-200
-4% -$12.6K
GE icon
120
GE Aerospace
GE
$319B
$287K 0.17%
3,763
-3,291
-47% -$220K
DT icon
121
Dynatrace
DT
$15.9B
$281K 0.16%
+6,640
New +$269K
SHW icon
122
Sherwin-Williams
SHW
$78.5B
$275K 0.16%
1,225
-25
-2% -$5.72K
XYL icon
123
Xylem
XYL
$25.1B
$272K 0.16%
2,600
SLB icon
124
SLB Ltd
SLB
$80.4B
$270K 0.16%
5,492
-11,375
-67% -$604K
MPC icon
125
Marathon Petroleum
MPC
$115B
$269K 0.16%
1,993
-300
-13% -$37.5K

Similar funds

New England Research & Management's Q1 2023 Portfolio in Review

As of Q1 2023, New England Research & Management held 180 positions worth $170M, down 2% from $174M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q1 2023 filing shows 28 new, 33 increased, 64 reduced and 37 closed positions. Its largest new stake was Charles Schwab: 30,305 shares worth $1.59M. The largest sale was Prosperity Bancshares, an estimated $2.95M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q1 2023 buy was Charles Schwab: 30,305 shares worth $1.59M.
  • New England Research & Management added most to Amgen in Q1 2023, an estimated $1.17M increase.
  • New England Research & Management's biggest Q1 2023 reduction was Merck, cutting an estimated $1.23M.
  • New England Research & Management fully exited Prosperity Bancshares in Q1 2023, selling an estimated $2.95M.
  • New England Research & Management's ten largest holdings make up 23% of its $170M portfolio in Q1 2023.
  • New England Research & Management opened 28 new positions and closed 37 in Q1 2023.
  • New England Research & Management's portfolio value fell 2% quarter-over-quarter to $170M.

Based on New England Research & Management's 13F filing for Q1 2023, filed 6 Apr 2023.